Literature DB >> 18234091

Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?

Virginie Levrat1, Isabelle Forest, Alain Fouilhoux, Cécile Acquaviva, Christine Vianey-Saban, Nathalie Guffon.   

Abstract

BACKGROUND: Hyperammonemia in patients with methylmalonic aciduria (MMA) and propionic aciduria (PA) is caused by accumulation of propionyl-CoA which decreases the synthesis of N-acetyl-glutamate, the natural activator of carbamyl phosphate synthetase 1. A treatment approach with carglumic acid, the structural analogue of N-acetyl-glutamate, has been proposed to decrease high ammonia levels encountered in MMA and PA crises. CASE
PRESENTATION: We described two patients (one with MMA and one with PA) with hyperammonemia at diagnosis. Carglumic acid, when associated with standard treatment of organic acidurias, may be helpful in normalizing the ammonia level.
CONCLUSION: Even though the usual treatment which decreases toxic metabolites remains the standard, carglumic acid could be helpful in lowering plasma ammonia levels over 400 micromol/L more rapidly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234091      PMCID: PMC2262878          DOI: 10.1186/1750-1172-3-2

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  7 in total

1.  Correlation between blood ammonia concentration and organic acid accumulation in isovaleric and propionic acidemia.

Authors:  F X Coude; H Ogier; G Grimber; P Parvy; D Pham Dinh; C Charpentier; J M Saudubray
Journal:  Pediatrics       Date:  1982-01       Impact factor: 7.124

2.  N-acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication.

Authors:  G Schubiger; C Bachmann; P Barben; J P Colombo; O Tönz; D Schüpbach
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

3.  N-carbamylglutamate protects patients with decompensated propionic aciduria from hyperammonaemia.

Authors:  B Gebhardt; S Dittrich; S Parbel; S Vlaho; O Matsika; H Bohles
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 4.  Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production.

Authors:  M Wajner; J C Coelho
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

Review 5.  Effects of hyperammonaemia on brain function.

Authors:  R F Butterworth
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

6.  N-carbamylglutamate enhances ammonia detoxification in a patient with decompensated methylmalonic aciduria.

Authors:  Boris Gebhardt; Stefan Vlaho; Doris Fischer; Adrian Sewell; Hansjosef Böhles
Journal:  Mol Genet Metab       Date:  2003-08       Impact factor: 4.797

7.  Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia.

Authors:  F X Coude; L Sweetman; W L Nyhan
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

  7 in total
  12 in total

1.  Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia.

Authors:  Bernd C Schwahn; Louisa Pieterse; W Michael Bisset; Peter G Galloway; Peter H Robinson
Journal:  Eur J Pediatr       Date:  2009-08-14       Impact factor: 3.183

2.  Short-term outcome of propionic aciduria treated at presentation with N-carbamylglutamate: a retrospective review of four patients.

Authors:  Sébastien Lévesque; Marie Lambert; Aspasia Karalis; Serge Melancon; Laura Russell; Nancy Braverman
Journal:  JIMD Rep       Date:  2011-09-06

3.  Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.

Authors:  Dashuang Shi; Gengxiang Zhao; Nicholas Ah Mew; Mendel Tuchman
Journal:  Mol Genet Metab       Date:  2016-12-08       Impact factor: 4.797

4.  Cobalamin C defect presenting as severe neonatal hyperammonemia.

Authors:  Diego Martinelli; Andrea Dotta; Laura Massella; Stefano Picca; Alessandra Di Pede; Sara Boenzi; Chiara Aiello; Carlo Dionisi-Vici
Journal:  Eur J Pediatr       Date:  2010-12-10       Impact factor: 3.183

5.  New developments in the treatment of hyperammonemia: emerging use of carglumic acid.

Authors:  Marta Daniotti; Giancarlo la Marca; Patrizio Fiorini; Luca Filippi
Journal:  Int J Gen Med       Date:  2011-01-07

6.  Clinical experience with N-carbamylglutamate in a single-centre cohort of patients with propionic and methylmalonic aciduria.

Authors:  Alberto Burlina; Chiara Cazzorla; Elisa Zanonato; Emanuela Viggiano; Ilaria Fasan; Giulia Polo
Journal:  Mol Genet Metab Rep       Date:  2016-07-13

7.  Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders.

Authors:  Cristel C Chapel-Crespo; George A Diaz; Kimihiko Oishi
Journal:  Expert Rev Endocrinol Metab       Date:  2016-09-28

Review 8.  Drug treatment of inborn errors of metabolism: a systematic review.

Authors:  Majid Alfadhel; Khalid Al-Thihli; Hiba Moubayed; Wafaa Eyaid; Majed Al-Jeraisy
Journal:  Arch Dis Child       Date:  2013-03-26       Impact factor: 3.791

9.  A liver-specific defect of Acyl-CoA degradation produces hyperammonemia, hypoglycemia and a distinct hepatic Acyl-CoA pattern.

Authors:  Nicolas Gauthier; Jiang Wei Wu; Shu Pei Wang; Pierre Allard; Orval A Mamer; Lawrence Sweetman; Ann B Moser; Lisa Kratz; Fernando Alvarez; Yves Robitaille; François Lépine; Grant A Mitchell
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

Review 10.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.

Authors:  Matthias R Baumgartner; Friederike Hörster; Carlo Dionisi-Vici; Goknur Haliloglu; Daniela Karall; Kimberly A Chapman; Martina Huemer; Michel Hochuli; Murielle Assoun; Diana Ballhausen; Alberto Burlina; Brian Fowler; Sarah C Grünert; Stephanie Grünewald; Tomas Honzik; Begoña Merinero; Celia Pérez-Cerdá; Sabine Scholl-Bürgi; Flemming Skovby; Frits Wijburg; Anita MacDonald; Diego Martinelli; Jörn Oliver Sass; Vassili Valayannopoulos; Anupam Chakrapani
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.